MedTrace Logo

Bellomic PCA in Laparoscopic Gynecologic Surgery

NCT05489796 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2023-05-18

No results posted yet for this study

Summary

In laparoscopic gynecological surgery, when intravenous patient-controlled analgesia (IV-PCA) device is used after surgery, the degree of postoperative side effects and pain control is compared when a combination of fentanyl and ketorolac is administered compared to when fentanyl alone is used.

Conditions

  • Laparoscopic Gynecological Surgery

Interventions

DRUG

Fentanyl selector

Selector (1 ml; Lock out 10 min): Fentanyl 200 mcg + N/S 16 ml = total 20 ml

DRUG

Fentanyl continuous

Continuous (2 ml/hr): fentanyl 700 mcg + N/S 86 ml = total 100 ml

DRUG

Ketorolac continuous

Continuous (2 ml/hr): Ketorolac 180 mg + N/S 94 ml = total 100 ml

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05489796 on ClinicalTrials.gov